Clinical Trial Update: An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on LYC-30937-EC in active ulcerative colitis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• LYC-30937-EC

Snippet

Sponsor: Lycera Corp. | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2019-04-02